David Sinclair (@davidasinclair) header
David Sinclair (@davidasinclair) profile picture

Professor researching why we age & how to reverse it. Author & host of Lifespan. Mission: Extend healthy life for all. Views are entirely his own. @joinlifespan

Harvard
Joined March 2012
Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)Photo by David Sinclair (@davidasinclair)
Balanced coverage of epigenetic age reversal tech 👏 @NPR lnk.to/Bk0Jr1
8
7
96
11,772
Working on it
skin longevity is quite literally coming
61
62
9
1,483
58,384
Simulation
The most entertaining outcome is the most likely, especially if ironic
26
18
3
429
39,561
It’s only right to warn patients of the potential risk of sudden blindness, however unlikely
22
11
1
317
47,362
It’s encouraging
Longevity industry is ripping 🔥🔥 My favorite part: Lilly and Novo are now using aging clocks as trial readouts, and patients on their drugs are reading biologically younger. Novo saw hearts up to 4 years younger vs placebo. @TheEconomist economist.com/business/2026/…
14
35
673
55,696
It’s holiday season
15
11
1
228
42,943
I feel far from wanting to get older, Not knowing what is around the corner. Time comes and goes, slips away, Melting away our years. I am waiting to change, To be again young. - Excerpt from The Race Against Time by V.G. Lopez, a 64-year-old poet, singer & lifelong student of human behavior
27
33
584
38,486
Image from this Sunday's Lifespan.com newsletter, with news about Congress and research funding, better sleep, Longevity Grok, neuroprotection, avoiding Ozempic face & approaching the Singularity
🤖 Made with AI
Excited to be on Lipfendra, the first oral PCSK9 inhibitor to prevent arterial plaque buildup Dramatic reductions seen in LDL, ApoB and Lp(a) So, what's it cost? How does it work? Is it worth it?
4
38
1
380
32,374
This is just the start. @biogerontology and I are already scoping 2.0 🙏
This is a great tool- but I am going to say the obvious- too difficult to understand!!
2
6
175
24,079
Longevity Grok, a.k.a. your personal longevity superintelligence (PLSI), is an open-source multi-agent workhorse designed to keep you alive & healthy for as long as possible. A collaborative effort from @InSilicoMeds & the Sinclair Lab @harvardmed. Visit longevitygrok.si
133
334
51
3,465
218,152
Excited to be on Lipfendra, the first oral PCSK9 inhibitor to prevent arterial plaque buildup Dramatic reductions seen in LDL, ApoB and Lp(a) So, what's it cost? How does it work? Is it worth it?
110
165
17
1,862
184,960
The current downside is it’s costing me $315 a month because it's not yet covered. What’s exciting is PCSK9 inhibition, previously available only through injections, is now possible with a once-daily pill
11
5
1
135
16,299
A study found no age-related decline in whole-blood NAD. Some trollfessors took that to mean NAD has no role in aging. Now Gardell and Baur explain why the report of the theory's death was an exaggeration 🧵 @NatMetabolism
19
29
1
354
37,116
The relative contributions of the Preiss–Handler and salvage pathways in red blood cells (the major cellular NAD reservoir in whole blood) and solid tissues are markedly different (depicted by arrow width)
2
23
3,283
Life’s short. Let’s fix that.
There is no application of AI and SI more impactful than Productive Longevity. Personal Longevity Superintelligence brought to you by my team and brilliant @davidasinclair and made possible with @bot . Grok Bot users get longevity superpowers - link at LongevityGrok.si
34
63
4
905
50,472
Have you read Lifespan News & Magazine: Try the free versions & don't miss out on breakthroughs, health tips, new trends, longevity protocols & investor info Memberships help support longevity research 🧬 Win-win. lifespan.com/pages/membershi…
11
26
238
19,510
ALS NEWS: Small molecule screen identifies SIRT1 as a key therapeutic target in ALS. SIRT1 activators hopeaphenol & SRT2104 (a SIRT1 activator with brain permeability & tolerability in humans) reduced motor neuron cell death, degeneration, and firing rates @NaturePortfolio
23
21
3
210
21,998